Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR08L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,714
Award facts
- Contract value 100% obligated
- $6,713.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $6,713.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injections on January 9, 2026. This non-competitive delivery order, valued at approximately $6.7K, will be fulfilled from the contractor's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of January 12, 2026. The award represents a task order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a $1 billion global pharmaceutical support vehicle that authorizes the company to supply comprehensive pharmaceutical products and medical commodities to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., functions as a major pharmaceutical distributor and critical federal medical procurement vendor. The company maintains extensive federal contracting experience delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Zepbound, a diabetes and weight management medication, aligns with the company's demonstrated capability to efficiently fulfill government requirements for prescription pharmaceuticals through open and competitive contracting mechanisms.
Quick answers
Who was awarded contract SPE2DR26FR08L?
SPE2DR26FR08L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FR08L worth?
The government has obligated $6,714 on SPE2DR26FR08L.
Is contract SPE2DR26FR08L an order under another contract?
Yes. SPE2DR26FR08L is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FR08L competed?
The extent of competition for SPE2DR26FR08L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award